Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice

Diabetes Technology and Therapeutics

Volumn 14, Issue 8, 2012, Pages 654-657

  Pepper, Gary M ^a   Steinsapir, Jamie ^a   Reynolds, Kathryn ^a  

^a Palm Beach Diabetes and Endocrine Specialists PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BIOSENSOR; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS INFUSION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FLORIDA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864663194     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0030     Document Type: Article

References (10)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
2. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
3. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J: Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79:1521-1526.
4. Allen NA, Fain JA, Braun B, Chipkin SR: Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract 2008;80:371-379.
5. Lenth RV: Java Applets for Power and Sample Size [computer software]. 2006-2009. www.stat.uiowa.edu/rlenth/Power (accessed January 8, 2012).
6. Rodbard D, Jovanovic L, Garg SK: Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther 2009;11:757-765.
7. Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovi-c L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV; AACE Continuous Glucose Monitoring Task Force, Rothermel C: Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010;16:730-745.
8. Wolpert HA: Continuous glucose monitoring-coming of age. N Engl J Med 2010;363:383-384.
9. Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, Wilson DM, Weinzimer S, Fiallo-Scharer R, Ruedy KJ; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technol Ther 2011;13:351-358.
10. Vigersky R, Fonda SJ, Chellappa M, Walker SM, Ehrhardt NM: Short-and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012;35:32-38.